Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > REGULATORY
REGULATORY
- PMDA to Raise Face-to-Face Advising Fees in April
February 12, 2014
- Takeda, 9 Other Drug Makers Join Hands in US NIH Initiative to Quest for New AD, Diabetes, RA Medicines
February 10, 2014
- Chuikyo to Submit Recommendations for FY2014 Medical Fee Revision on Feb. 12
February 10, 2014
- Warning on Interstitial Pneumonia to Be Added to Precautions Section of Package Insert for Rivaroxaban
February 10, 2014
- Bill Payers, Healthcare Providers Agree to Increase Medical Fees, Dispensing Fees
February 7, 2014
- Regulatory Reform Council Selects “Switch-OTC In Vitro Diagnostics” as Target for “International Benchmark Test”
February 7, 2014
- FY2014 NHI Drug Pricing Reform –Part 1: New Rules Will Spur Efforts to Escape Dependence on Long-Listed Drugs, Spark Reorganization of Generic Industry
February 7, 2014
- FY2014 NHI Drug Pricing Reform –Part 2: Introduction of New Rule for Long-Listed Drugs, Elimination of Special Price Cuts Could Spark Shift to New Drugs, Use of AG Strategy
February 7, 2014
- Fiscal Impact Assessment for Key Premium Added to Chuikyo’s Supplementary Opinions for FY2014 Revision
February 6, 2014
- Submission of Draft Bills to Establish Japanese Version of US NIH Approved in Joint Session, “NIH” Will Not Be Part of Name
February 6, 2014
- PMDA’s Next 5-Year Plan to Embrace New Generic Unit, Benchmarks for Review Time
February 5, 2014
- Revised PAL, Pharmacists Law to Take Effect on June 12
February 5, 2014
- PAFSC’s Second Committee Backs Prostate Cancer Drug Enzalutamide
February 4, 2014
- PMDA Raises Caution about Using Factor Xa Inhibitor Xarelto, Citing Risk of Interstitial Pneumonia
February 4, 2014
- Wholesalers Call on Drug Makers to “Flexibly” Revise Invoice Prices
February 3, 2014
- PAFSC Committee Designates OTC PMS Treatment as First “Drug Requiring Guidance”
January 31, 2014
- Medical Fee Cuts Will Start from FY2014 to Improve Delivery Price Settlement Rates: Chuikyo
January 30, 2014
- Wary of Drug Price Negotiations Dragging Out into FY2014, MHLW to Survey Price Agreement Rate in March
January 30, 2014
- 2 Bills Related to the Establishment of a “Japanese NIH” to Be Submitted to the Diet in Early February
January 30, 2014
- 3 Entities Strike Codevelopment Deal for Adult TB Vaccines
January 29, 2014
ページ
Adeno-associated virus (AAV) gene therapies have long been viewed as carrying only a minimal risk of insertional mutagenesis — a…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…